Jefferies Group LLC Pro Qr Therapeutics N.V. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.0 $6,370 - $11,375	-11,375 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$0.9 - $8.39 $10,237 - $95,436	11,375 New	11,375 $10,000
Q1 2022 May 16, 2022	BUY	$0.9 - $8.39 $10,237 - $95,436	11,375 New	11,375 $10,000
Q1 2019 May 15, 2019	SELL	$12.5 - $18.48 $500,000 - $739,200	-40,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $610,000 - $896,000	40,000 New	40,000 $631,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.